Lexicon Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.11.24	FDA Panel Votes Against Lexicon's NDA For Zynquista In Type 1 Diabetes And Chronic Kidney Disease (RTTNews)
30.09.24	Biotech Stocks Facing FDA Decision In October 2024 (RTTNews)
16.09.24	Lexicon Pharmaceuticals COO Jeff Wade To Step Down (RTTNews)
10.09.24	Lexicon Pharma Reports Data From SOTA-INS CGM Phase 3 Randomized Trial - Quick Facts (RTTNews)
03.09.24	Lexicon Pharma: INPEFA Benefits Heart Failure Patients Regardless Of Diabetes Duration (RTTNews)
21.08.24	Lexicon Pharma Announces FDA Advisory Committee Meeting For Zynquista (RTTNews)
18.08.24	Biotech Buzz: VIRX Cuts 23% Jobs, FDA Oks New Drug For Hypoparathyroidism, SIGA Down But Not Out (RTTNews)
13.08.24	Lexicon Pharma To Cut About 50% Of Workforce By Q3, Stock Up (RTTNews)
08.07.24	Lexicon Pharmaceuticals Appoints Mike Exton As CEO (RTTNews)
21.06.24	Lexicon Pharma Resubmits Sotagliflozin NDA For Type 1 Diabetes; Stock Up In Pre-market (RTTNews)
29.04.24	Lexicon Pharmaceuticals CEO Lonnel Coats To Retire (RTTNews)
12.03.24	Lexicon Announces Positive Data Of InTandem3 Study In Type 1 Diabetes Patients With CKD; Stock Down (RTTNews)
01.06.23	Pre-market Movers: AGBA, QSG, AI, OKTA, AULT… (RTTNews)
26.05.23	FDA Approves Lexicon Pharma's Inpefa For Treatment Of Heart Failure (RTTNews)
18.08.22	Pre-market Movers: BRSH, CDAK, BWV, WOLF, AVGR… (RTTNews)
03.08.22	ATRC Sees 18-21% Revenue Growth, EVH Q2 Results Beat Estimates, EXAS Trims Outlook, HRMY On Watch... (RTTNews)
06.06.22	Pre-market Movers: DIDI, EVTL, YMM, LXRX, BZ… (RTTNews)
28.02.22	Lexicon Pharma Voluntarily Withdraws Sotagliflozin New Drug Application (RTTNews)
31.12.21	Lexicon Seeks Approval Of Sotagliflozin For Use In Type 2 Diabetes Patients With Heart Failure (RTTNews)
15.01.21	FDA Expands Approved Use Of PFE's Xalkori, LXRX Soars On Sotagliflozin Update, BCYC Hits New High (RTTNews)
14.01.21	Stock Alert: Lexicon Pharmaceuticals Surges 35% (RTTNews)
16.12.20	After Hours Market: Wunong Net, Lexicon Pharma, Scopus BioPharma Gain; Upstart Holdings Slips (RTTNews)
11.12.20	Lexicon Pharma: LX9211 Receives Fast Track Designation - Quick Facts (RTTNews)
19.11.20	Pre-market Movers In Healthcare Sector: APVO, CORT, TTNP, BLU, MGTX... (RTTNews)
18.11.20	Pre-market Movers In Healthcare Sector: KZIA, LMNL, OCGN, INO, ONCT... (RTTNews)
18.11.20	BCLI Flunks Phase II ALS Study, LXRX Aces Sotagliflozin Trials, KZIA On Watch, FDA Snubs ALKS (RTTNews)
17.11.20	Pre-market Movers In Healthcare Sector: LXRX, NEPT, VXRT, BNTX, CVAC… (RTTNews)
31.07.20	Pre-market Movers In Healthcare Sector: ACHV, ECOR, ADMA, DBVT, PRPO... (RTTNews)
31.07.20	PRPO Up 400% As It Readies For Rollout Of COVID-19 Test, LXRX Realigns Business, VRTX Boosts Outlook (RTTNews)
03.12.19	AGTC Awaits Data In Jan., EVFM Walks The Talk, Today's A Big Day For ALDX (RTTNews)
19.09.19	5 Top Gainers In Healthcare Sector (LXRX, ECOR, ARAV…) (RTTNews)
17.09.19	7 Top Gainers In Healthcare Sector (KOD, LXRX, WVE...) (RTTNews)
14.09.19	Week Ahead In Pharmaceuticals: 7 Stocks To Watch (AIMT, LXRX, TXG…) (RTTNews)
06.08.19	5 Top Gainers In Healthcare Sector (ALLK, IMGN, LXRX...) (RTTNews)
01.08.19	5 Top Losers In Healthcare Sector (TTOO, LXRX, ACRS…) (RTTNews)
30.07.19	6 Top Losers In Healthcare Sector (LXRX, XBIO, ONCY...) (RTTNews)
27.07.19	Sanofi Terminates Partnership With Lexicon To Develop Diabetes Drug (RTTNews)
27.02.19	Biotech Stocks Facing FDA Decision In March (RTTNews)
18.01.19	FDA Turns Down IMMU's Breast Cancer Drug, MGNX/LLY Deal Progresses, ZFGN Abuzz (RTTNews)
18.01.19	FDA Advisory Panel Splits Vote On Sanofi-Lexicon Diabetes Drug (RTTNews)
24.12.18	Biotech Stocks Facing FDA Decision In January 2019 (RTTNews)
31.07.18	LXRX On Watch, NKTR To Face FDA In May, TNDM Boosts Sales Outlook (RTTNews)
25.06.18	LLY Scores Win In Alimta Patent Suit, LXRX For The Long Haul, MNKD Breathes Easy (RTTNews)
01.06.18	Shifting Social Trends in China to Drive Positive Growth in China Luxury Car Market, notes Frost & Sullivan (PR Newswire)
22.05.18	Lexicon Pharma: FDA To Review Sanofi's Filing For Zynquista - Quick Facts (RTTNews)
22.05.18	FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes (PR Newswire)
29.03.18	Sanofi: EMA To Review Regulatory Submission For Sotagliflozin - Quick Facts (RTTNews)
27.11.17	Commercial Metals Company Names Barbara Smith Chairman (PR Newswire)
08.11.17	Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides A Business Update (PR Newswire)
03.11.17	Lexicon Pharmaceuticals To Host Third Quarter 2017 Financial Results Conference Call And Webcast On November 8, 2017 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Lexicon Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten